This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Community Health (CYH) Incurs Lower Loss Than Expected in Q2
by Zacks Equity Research
Community Health's (CYH) Q2 results suffer loss from decline in admissions.
Implied Volatility Surging for Community Health (CYH) Stock Options
by Zacks Equity Research
Community Health (CYH) needs investors to pay close attention to the stock based on moves in the options market lately.
Community Health Arm to Divest AllianceHealth Deaconess
by Zacks Equity Research
Community Health (CYH) subsidiary to sell AllianceHealth Deaconess hospital in Oklahoma City to INTEGRIS Health's unit.
Community Health's Ratings Downgraded by Moody's
by Zacks Equity Research
Moody's downgrades the ratings of Community Health (CYH). The outlook of the company stays stable.
Community Health (CYH) Up 8.3% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Community Health (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Community Health (CYH) Posts Earnings in Q1, Revenues Top
by Zacks Equity Research
Community Health's (CYH) Q1reflects expansion in transfer and access program, launch of Accountable Care Organizations, and investments in outpatient capabilities and service line. However, admissions declined.
Implied Volatility Surging for Community Health (CYH) Stock Options
by Zacks Equity Research
Community Health (CYH) needs investors to pay close attention to the stock based on moves in the options market lately.
Why did Community Health Stock Sink More Than 50% in a Year?
by Zacks Equity Research
Community Health (CYH) underperforms the industry due to rising expenses, ailing revenues and a weak guidance.
Tenet Healthcare Sells MacNeal Hospital to Streamline Trade
by Zacks Equity Research
Tenet Healthcare's (THC) divestitures aim at debt repayment, reduction of interest burden and streamlining of core business.
Options Traders Expect Huge Moves in Community Health (CYH) Stock
by Zacks Equity Research
Investors in Community Health (CYH) need to pay close attention to the stock based on moves in the options market lately.
Can Revenue Rise Aid Envision Healthcare (EVHC) Q4 Earnings?
by Zacks Equity Research
Envision Healthcare (EVHC) Q4 earnings might see an upside from higher revenues in Physician Services segment, partly offset by high expenses and lower revenues from Ambulatory Service segment.
Will Higher Revenues Buoy Teladoc's (TDOC) Q4 Earnings?
by Zacks Equity Research
Teladoc's (TDOC) fourth-quarter 2017 results to benefit from an increase in members utilizing its services, higher visits and growing client roaster.
Will Lower Volume Hurt Tenet Healthcare's (THC) Q4 Earnings?
by Zacks Equity Research
Industry-wide softness in admissions might affect Tenet Healthcare's (THC) fourth-quarter results.
Is a Surprise Coming for Community Health (CYH) This Earnings Season?
by Zacks Equity Research
Given that Community Health (CYH) has a Zacks Rank #3 (Hold) and an ESP in positive territory, investors might want to consider this stock ahead of earnings.
4 Health Care Stocks Set to Beat Earnings Estimates in 4Q
by Zacks Equity Research
This attractive sector has several companies with upside potential.
Can Solid Medicaid Business Boost Centene (CNC) Q4 Earnings?
by Zacks Equity Research
Centene's (CNC) fourth-quarter results are expected to be supported by membership growth and cost-saving initiatives.
HCA Healthcare's Top Line Grows on Buyouts, Bad Debts Hurt
by Zacks Equity Research
Although HCA Healthcare's (HCA) top line continues to grow on the back of admissions, industry wide softness in volume, political uncertainty and high bad debt bother.
Options Traders Expect Huge Moves in Community Health (CYH) Stock
by Zacks Equity Research
Surging implied volatility makes Community Health (CYH) stock lucrative to the option traders.
Will Community Health Bounce Back in 2018 After a Dismal 2017?
by Zacks Equity Research
Community Health (CYH) suffered in 2017 from weak volumes and high costs. Let's see how this year unfolds.
Options Traders Expect Huge Moves in Community Health (CYH) Stock
by Zacks Equity Research
Options Traders expect huge moves in Community Health (CYH) stock on the back of its surging implied volatility.
Tenet Healthcare Sells Hospital Unit to Streamline Business
by Zacks Equity Research
Tenet Healthcare (THC) sells its hospital unit to focus on core growth areas.
HCA Healthcare Rides on Acquisitions, Weak Volumes Bother
by Zacks Equity Research
A number of acquisitions have added facilities and widened network at HCA Healthcare (HCA). Weak admissions, however, continue to bother.
The Ensign Group (ENSG) Buys 2 Nursing Facilities in Arizona
by Zacks Equity Research
The Ensign Group's (ENSG) acquisition spree should aid its top-line growth.
4 Healthy Stocks from an Ailing Hospital Industry
by Zacks Equity Research
Despite challenges like weak patient volume and increasing uninsured rates, the hospital industry is positioned for long-term growth.
Community Health System Divests Hospitals to Lower Debts
by Zacks Equity Research
Community Health Systems, Inc. (CYH) resorts to divestitures in order to finance its long-term debts.